December 18, 2008 - Doctors at the Cancer Treatment Services in Casa Grande, AZ, have begun treating cancer patients with a reportedly fast and precise form of radiotherapy, using RapidArc radiotherapy technology by Varian Medical Systems.

December 12, 2008 - Patients with breast cancer whose tumors were HER2-positive and one centimeter or smaller had a significant risk of relapse compared with other tumor types, according to a new study presented at the CRTC-AACR San Antonio Breast Cancer Symposium.

December 18, 2008 — Emageon Inc. announced that its stockholders voted to approve Emageon’s proposed merger with Health Systems Solutions Inc. at a special meeting of stockholders held at Emageon’s offices yesterday.

December 18, 2008 — AngioDynamics Inc. announced the use of its irreversible electroporation (IRE) technology on a lymph node metastasis and the first lung lesion case at The Alfred in Melbourne, Australia.

December 17, 2008 – Teleradiology provider Imaging On Call said it signed contracts with Orange Radiology Associates in Monroe, NY and Interfaith Medical Center based in Brooklyn, NY. Imaging On Call offers various packages, including preliminary or final reads, subspecialty reads, vacation coverage, post processing and interpretation for coronary CTA and breast MRI.

December 16, 2008 - Rcadia Medical Imaging Ltd., developer of the COR Analyzer software for the automated analysis of coronary CT angiography (CCTA) studies, closed a $3.3M investment round led by BioVentures Investors of Cambridge, MA.

December 16, 2008 – Researchers from Yale University School of Medicine compared narrow-band imaging (NBI) without high magnification to standard white light colonoscopy in differentiating colorectal polyps during real-time colonoscopy and found that NBI was not more accurate than white light colonoscopy.

December 15, 2008 - Breast conserving surgery is not improved by the addition of MRI to other conventional staging assessments, according to a study presented at the San Antonio Breast Cancer Symposium.

December 15, 2008 - Lantheus Medical Imaging reported that new data from a retrospective, multicenter, cohort study of over four million hospitalized patients showed similar unadjusted mortality rates for patients receiving DEFINITY Vial for (Perflutren Lipid Microsphere) Injectable Suspension enhanced resting echocardiography exams when compared with patients who did not receive DEFINITY.